BioSpace News Archive

A New Business Strategy report released by Data Bridge Market Research with the title Global Active Pharmaceutical Ingredients (API) Market Study Forecast till 2028.

Eurofins DiscoverX announced the official opening of its new China biotechnology office in Shanghai.

A New Business Strategy report released by Data Bridge Market Research with the title Global Autoimmune Disease Diagnosis Market Study Forecast till 2029.

StarAligners, Inc, a leader and innovator of clear aligners, orthodontic products, and solutions, announces the launch of Illumina™, an innovative orthodontic product new to the market.

3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, announced completion of the first series of US surgeries in the BalancedBack Total Joint Replacement Investigational Device Exemption pivotal clinical trial.

A New Research on the Artificial Intelligence (AI) in Drug Discovery Market was conducted across a variety of industries in various regions to produce more than 350+ page reports.

Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced an executive leadership transition.

Corcept Therapeutics Incorporated announced that it has initiated ROSELLA, a pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the steps it is taking to explore every available pathway to accelerate the decision by the U.S. Food and Drug Administration (FDA) to grant final approval of its lead drug candidate, FT218, prior to June 2023.

Poseida Therapeutics, Inc. (Nasdaq: PSTX), today announced a peer-reviewed publication highlighting the potential of its proprietary Cas-CLOVER Site-specific Gene Editing System as a high-efficiency platform for the production of allogeneic CAR-T cells.